CNS Pharmaceuticals, Inc. (CNSP) vs Senti Biosciences, Inc. (SNTI)
- CNS Pharmaceuticals, Inc. CNSP 4.85 −6.37%
- Senti Biosciences, Inc. SNTI 0.22 −15.38%
CNS Pharmaceuticals, Inc. and Senti Biosciences, Inc. are both Biotechnology companies. CNS Pharmaceuticals, Inc. and Senti Biosciences, Inc. are of similar size ($8.1M and $7.9M). CNS Pharmaceuticals, Inc. has the higher net margin (0.00% vs −3,789.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, CNS Pharmaceuticals, Inc. leads on 9 and Senti Biosciences, Inc. on 2.
Valuation
Profitability
| Metric | CNSP | SNTI | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (4,181.12%) | 0.00% |
| Net margin | 0.00% | (3,789.30%) | 0.00% |
| Free cash flow margin | 0.00% | (2,900.38%) | 0.00% |
| Return on equity | (106.62%) | (466.46%) | (56.36%) |
| Return on assets | (91.64%) | (97.52%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack